| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting & tax | 29,671 | 0 | 0 | 0 |
| Identifier | Return Reference | Explanation |
|---|---|---|
| General Explanation Supplemental Information for Form 990-PF | Expenditure Responsibility StatementPart VII-B Line 5CGrantee's Name: CK-12Grantee's Address: 1760 The Alameda Suite 300, San JoseGrant Amount: $10,540,000.Date of Grant: Various 2018Amount Expended: $10,540,000.Purpose of Grant:To directly support the activities of the CK12 Foundation to develop and operate an open educational source for teaching, learning and research resources that reside in the public domain or have been released under an intellectual property license that permits their free use or repurposing by others.The Executive Director of the Grantee is the President of the Grantor. All expenditures and reports are monitored in real time. Of the $10,540,000 given in 2018, all was used for the stated purpose.To the knowledge of the Grantor, no funds have been diverted to any activity other than activity for which the grant was originally made.Any Diversion by Grantee: NoneResults of Verification:The Grantor has no reason to doubt the accuracy or reliability of the report from the Grantee; therefore no independent verification of the report was made. | |
| General Explanation Supplemental Information for Form 990-PF | Expenditure Responsibility StatementPart VII-B Line 5CGrantee's Name: Open Medicine InstituteGrantee's Address: 2500 Hospital Drive - Building 2, Mountain View, CA 94040Grant Amount: $500,000Date of Grant: 3/19/18Amount Expended: $500,000.Purpose of Program related investments:To directly support T-cell study.To the knowledge of the Grantor, no funds have been diverted to any activity other than activity for which the grant was originally made.Any Diversion by Grantee: NoneResults of Verification:The Grantor has no reason to doubt the accuracy or reliability of the report from the Grantee; therefore no independent verification of the report was made. |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| KPCB IXA | AT COST | 207,359 | 50,516 |
| Brillio aka Collabera Solutions | AT COST | 997,498 | 86,000 |
| CK12 India | AT COST | 1 | 1 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| Kashf Holding (PRI) | 229,000 | 229,000 | |
| Loan to Cortene, Inc. | 200,000 | 200,000 | 217,571 |
| Loan to OMI (PRI) | 2,823,000 | 3,173,000 | 3,028,000 |
| Short-term receivable | 24,518 | ||
| Unitus Seed Fund (PRI) | 89,540 | 133,333 | 131,950 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Other nondeductible | 6 | |||
| Passthrough expenses | 8,869 | 8,869 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CA Tax | 10 | |||
| Excise tax expense | 38,788 | |||
| Filing fees | 150 |